Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,157,623
-
Share change
-
-4,631,874
-
Total reported value
-
$9,865,012
-
Put/Call ratio
-
1646%
-
Price per share
-
$0.52
-
Number of holders
-
52
-
Value change
-
-$3,188,787
-
Number of buys
-
12
-
Number of sells
-
47
Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q3 2020
As of 30 Sep 2020,
ACORDA THERAPEUTICS INC - COM (ACOR) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,157,623 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., ACADIAN ASSET MANAGEMENT LLC, Parallax Volatility Advisers, L.P., BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, GSA CAPITAL PARTNERS LLP, FEDERATED HERMES, INC., and Invesco Ltd..
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.